FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefoxitin for Injection, USP
Status: Currently in Shortage
»Date first posted: 05/03/2019
»Therapeutic Categories: Anti-Infective

Expand all

Apotex Corp. (Reverified 11/27/2019)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (25 vials) (NDC 60505-0759-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
2 g (25 vials) (NDC 60505-0760-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
10 g (10 vials) (NDC 60505-0761-04) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug

Fresenius Kabi USA, LLC (Reverified 12/09/2019)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g per vial; SDV; (NDC 63323-341-25) Backordered. Next release January 2020. Check wholesalers for inventory Manufacturing delays
2 grams per vial; SDV; (NDC 63323-342-25) Backordered. Next release January 2020. Check wholesalers for inventory Manufacturing delays

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 12/13/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1g vial (NDC 0143-9878-25) Available Additional lots will be scheduled for manufacturing Product will be made available as it is released. Demand increase for the drug
2g vial (NDC 0143-9877-25) Available Additional lots will be scheduled for manufacturing Product will be made available as it is released. Demand increase for the drug
10g vial (NDC 0143-9876-10) Available Additional lots will be scheduled for manufacturing Product will be made available as it is released. Demand increase for the drug

Sagent Pharmaceuticals (Reverified 12/13/2019)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 g, package of 10 vials (NDC 25021-111-99) On backorder. Product continues to be manufactured with monthly releases. Estimated availability Feb-2020 Demand increase for the drug
1 g, package of 10 vials (NDC 25021-109-10) Available. On allocation Manufacturing delay
2 g, package of 10 vials (NDC 25021-110-20) On allocation. Product continues to be manufactured with monthly releases. Estimated availability Jan-2020 Demand increase for the drug

WG Critical Care (Revised 11/04/2019)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (NDC 44567-245-25) On backorder. Next release December. Please check wholesalers for available inventory. Demand increase for the drug
2 g (NDC 44567-246-25) On backorder. Next release December. Please check wholesalers for available inventory. Demand increase for the drug
10 g (NDC 44567-247-10) On backorder. Next release December. Please check wholesalers for available inventory. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English